Immunic, Inc.
IMUX
$1.18
-$0.02-1.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.32% | -6.34% | -6.85% | 1.56% | -7.37% |
| Total Depreciation and Amortization | 25.37% | 31.97% | 42.98% | 43.81% | 20.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -38.73% | -34.22% | -44.72% | -48.82% | 100.35% |
| Change in Net Operating Assets | 456.97% | -40.40% | -57.87% | -20.87% | -97.81% |
| Cash from Operations | -1.23% | -18.01% | -24.60% | -9.68% | -19.68% |
| Capital Expenditure | 39.02% | 64.08% | 67.62% | -7.28% | 20.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 39.02% | 64.08% | 67.62% | -106.84% | -102.79% |
| Total Debt Issued | -- | -100.00% | -100.00% | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 23,833.21% | 8,151.70% | 5,991.09% | -92.92% | -73.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -12.03% | -12.62% | -12.95% | -99.90% | 7,115.97% |
| Foreign Exchange rate Adjustments | 139.65% | -81.23% | 265.36% | -179.18% | -297.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -83.40% | -3,773.62% | -1,114.48% | -1,923.95% | 81.68% |